Li-Xuan Qin

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

William Lee, Sewit Teckie, Thomas Wiesner et al. · Nature Genetics · 2014 · 633 citations · Full text

Medicine, Cancer Biology, Oncology +11

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

Robert G. Maki, David R. D’Adamo, Mary Louise Keohan et al. · Journal of Clinical Oncology · 2009 · 573 citations · Full text

Medicine, Oncology, Cancer Pharmacology +15

γ-Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced Chemosensitivity

Raymond D. Meng, Christopher C. Shelton, Yue-Ming Li et al. · Cancer Research · 2009 · 301 citations · Full text

Medicine, Oncology, Pharmacology +17

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations

Shinji Kohsaka, Neerav Shukla, Nabahet Ameur et al. · Nature Genetics · 2014 · 186 citations · Full text

Medicine, Molecular Biology, Oncology +14

A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients

Robert J. Canter, Li-Xuan Qin, Robert G. Maki et al. · Clinical Cancer Research · 2008 · 184 citations · Full text

Medicine, Oncology, Surgery +13